SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-007038
Filing Date
2023-03-09
Accepted
2023-03-09 16:15:40
Documents
14
Period of Report
2023-03-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hsto-20230309.htm   iXBRL 8-K 64987
2 EX-99.1 hsto-ex99_1.htm EX-99 263658
3 GRAPHIC img196544735_0.jpg GRAPHIC 2092
  Complete submission text file 0000950170-23-007038.txt   469356

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hsto-20230309.xsd EX-101.SCH 2474
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hsto-20230309_pre.xml EX-101.PRE 11118
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hsto-20230309_lab.xml EX-101.LAB 17752
8 EXTRACTED XBRL INSTANCE DOCUMENT hsto-20230309_htm.xml XML 4699
Mailing Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121
Business Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121 (858) 526-3100
Histogen Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36003 | Film No.: 23719931
SIC: 2834 Pharmaceutical Preparations